Abstract
The present study was aimed at formulating tablets comprising of coating susceptible to microbial enzyme degradation for releasing budesonide in the colon. Tablets prepared by using Avicel® pH 102 as diluent and Eudragit® L100-55 as binder were coated to a weight gain of 10% w/w employing aqueous mixtures containing chitosan (CH) and chondroitin sulfate (CS). The interpolymer complex between CH and CS was characterized using Fourier transform infrared (FTIR) and differential scanning calorimetery (DSC) studies. The tablets were evaluated for release of budesonide through in vitro in vivo studies. Formation of bonds between –COO− and –OSO −3 groups of CS and –NH +3 groups of CH was evident in the FTIR spectra of these interpolymer complexed (IPC) films. The DSC thermograms of these films revealed one endothermic transition between 190°C and 205°C, suggesting the formation of new bonds in the IPC. The pH sensitive swelling exhibited by these films was observed to be a function of CH concentration. Tablets coated with aqueous mixtures containing 40:60 or 50:50 ratio of CH/CS totally prevented the release of budesonide in pH 1.2 buffer. The peaks (FTIR) and endothermic transitions (DSC) characteristic of interpolymer complexation were observed to remain unaffected after sequential exposure of the films to pH 1.2 and pH 7.4 buffer IP. This proved the versatility of these IPC films for colon delivery. C max of 1,168.99 and 1,174.2 ng/mL, respectively, at 12 and 8 h post-oral dosing of tablets coated with 40:60 or 50:50 ratio of CH/CS was observed in rats. The aqueous CH/CS (40:60) coating could provide a facile method for delivering budesonide to the colon.
Similar content being viewed by others
References
Friend DR. New oral delivery systems for treatment of inflammatory bowel disease. Adv Drug Deliv Rev. 2005;57:247–65.
Robinson M. Medical therapy of inflammatory bowel disease for the 21st century. Eur J Surg. 1998;582:90–8.
Rahimi R, Nikfar S, Rezaie A, Abdollahi M. A meta-analysis of broadspectrum antibiotic therapy in patients with active Crohn's disease. Clin Ther. 2006;28:1983–8.
Klein S, Stein J, Dressman J. Site speific delivery of anti-inflammatory drugs in the gastrointestinal tract: an in vitro release model. J Pharm Pharmacol. 2005;57:709–19.
Spencer CM, McTavish D. Budesonide: a review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease. Drugs. 1995;50:854–72.
Akhgari A, Sadeghi F, Garekani HA. Combination of time-dependent and pH-dependent polymethacrylates single coating formulation for colonic delivery of indomethacin. Int J Pharm. 2006;320:137–42.
Niwa K, Takaya T, Morimoto T, Takada K. Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs. J Drug Target. 1995;3:83–9.
Sinha VR, Kumria R. Microbially triggered drug delivery to the colon. Eur J Pharm Sci. 2003;18:3–18.
Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. Measurement of gastrointestinal pH profiles in normal ambulant subjects. Gut. 1988;29:1035–41.
Davis SS, Hardy JG, Stockwell A, Taylor MJ, Whalley DR, Wilson CG. The effect of food on the gastrointestinal transit of pellets and an osmotic device (Osmet). Int J Pharm. 1984;21:331–40.
Wong D, Larrabee S, Clifford K, Tremblay J, Friend DR. USP dissolution apparatus II (reciprocating cylinder) for screening of guar gum-based colonic delivery formulations. J Control Rel. 1997;47:73–179.
Raghavan CV, Muthulingam C, Jenita JAJL, Ravi TK. An in vitro in vivo investigation into the suitability of bacterially triggered delivery system for colon targeting. Chem Pharm Bull. 2002;50:892–5.
Siew LF, Basit AW, Newton JM. The properties of amylase ethylcellulose films cast from organic-based solvents as potential coatings for colonic drug delivery. Eur J Pharm Sci. 2000;11:133–9.
Ahmed IS. Effect of simulated gastrointestinal conditions on drug release from pectin/ethylcellulose as film coating for drug delivery to the colon. Drug Dev Ind Pharm. 2005;31:465–70.
Gliko-Kabir I, Yagen B, Penhasi A, Rubinstein A. Low swelling, crosslinked guar gum and its potential use as colon-specific drug carrier. Pharm Res. 1998;15:1019–25.
Fan J, Wang K, Liu M, He Z. In vitro evaluations of konjac glucomannan and xanthan gum mixture as the sustained release material of matrix tablet. Carbohydr Polym. 2008;73:241–7.
Muzzarelli C, Vesna Stanic V, Gobbi L, Tosi G, Muzzarelli R. Spray drying of solutions containing chitosan together with polyuronans and characterisation of the microspheres. Carbohydr Polym. 2004;57:73–82.
Xia W, Liu P, Liu J. Advance in chitosan hydrolysis by non-specific cellulases. Biores Technol. 2008;99:6751–62.
Indian Pharmacopeia. Indian Pharmacopeia Commission, Ghaziabad; 2007.
Marvola M, Nykänen P, Rautio S, Isonen N, Autere A-M. Enteric polymers as binders and coating materials in multiple-unit site specific drug delivery systems. Eur J Pharm Sci. 1999;7:259–67.
US Pharmacopeia XXX NF XXV. US Pharmacopeial convention, Rockville; 2007.
Zambito Y, Baggiani A, Carelli V, Serafini MF, Colo GD. Matrices for site specific controlled delivery of 5 fluorouracil to descending colon. J Control Release. 2005;102:669–77.
Rodríguez M, Vila-Jato J, Torres D. Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J. Control. Rel. 1998;55:67–77.
Rubinstein A, Radai R, Ezra M, Pathak S, Rokem JS. In vitro evaluation of calcium pectinate: a potential colon specific drug delivery carrier. Pharm Res. 1993;10:258–63.
Gupta M, Bhargava HN. Develpoment and validation of high performance liquid chromatographic method for the analysis of budesonide. J Pharm Biomed Anal. 2006;40:423–8.
Sui W, Huang L, Wang J, Bo Q. Preparation and properties of chitosan chondroitin sulfate complex microcapsules. Colloids and Surfaces B Biointerfaces. 2008;65:69–73.
Kemp W. Infrared spectroscopy, in organic spectroscopy. London: MacMillan; 1991.
Berger J, Reist M, Mayer JM, Felt O, Peppas NA, Gurny R. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur J Pharm Biopharm. 2004;57:19–34.
Hawksworth G, Drasar BS, Hill MJ. Intestinal bacteria and the hydrolysis of glycosidic bonds. J Med Microbiol. 1971;155:451–9.
Zhang H, Alsara IA, Neau SH. An in vitro evaluation of a chitosan containing multiparticulate system for macromolecular delivery to the colon. Int J Pharm. 2002;239:197–205.
Ofori-Kwakye K, Fell JT. Biphasic drug release from film coated tablets. Int J Pharm. 2003;250:431–40.
Möllmann HW, Hochhaus G. Pharmacokinetics and pharmacodynamics of budesonide after oral application of 1 × 3 mg budesonide as Budenofalk 3 mg capsules to healthy subjects with and without breakfast. Data on file, Dr. Falk Pharma, Freiburg/Germany; 1998.
Edsbacker S, Larsson P, Wollmer P. Gut delivery of budesonide, a locally active corticosteroid, from plain and controlled-release capsules. Eur J Gastroenterol Hepatol. 2002;14:1357–62.
Acknowledgments
The author wish to acknowledge the help rendered by M/S Scientific and Digital Systems, New Delhi, India for providing the facilities of Texture Analyzer for carrying out mechanical tests on CH/CS IPC films.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaur, G., Rana, V., Jain, S. et al. Colon Delivery of Budesonide: Evaluation of Chitosan–Chondroitin Sulfate Interpolymer Complex. AAPS PharmSciTech 11, 36–45 (2010). https://doi.org/10.1208/s12249-009-9353-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-009-9353-8